Vitality Biopharma, Inc. (OTCMKTS:VBIO) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 2,300 shares, a growth of 360.0% from the December 31st total of 500 shares. Based on an average trading volume of 43,400 shares, the days-to-cover ratio is currently 0.1 days.
Vitality Biopharma stock opened at $0.10 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.23 and a quick ratio of 1.23. Vitality Biopharma has a fifty-two week low of $0.01 and a fifty-two week high of $0.50. The firm has a fifty day moving average price of $0.08 and a two-hundred day moving average price of $0.14.
Vitality Biopharma (OTCMKTS:VBIO) last posted its quarterly earnings data on Friday, November 13th. The company reported ($0.01) EPS for the quarter.
Vitality Biopharma Company Profile
Vitality Biopharma, Inc engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes.
Read More: Retained Earnings